undamentalytics Newsletter

Harris C Martin: insider trades

Director at 3 companies we cover. No open-market purchases and 16 sales not made under a pre-set plan, reported from May 29, 2013 to February 2, 2024.

What happened after Harris C Martin’s sales?

After their sales, the shares moved −3.0% against the index over 12 months on average (a negative figure means selling was the right call); 63% trailed it.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

Trade by trade

Harris C Martin: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 0 — — — — — — Not enough years
Purchases, 6 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the trade 0 — — — — — — Not enough years
Sales, 3 months after the report 16 +3.9% +1.7% 19% 10 2.56 0.031 Some evidence: seller wrong
Sales, 12 months after the report 16 −3.0% −1.7% 63% 10 −1.24 0.25 No reliable evidence
Sales, 12 months after the trade 16 −2.5% −0.6% 56% 10 −0.97 0.36 No reliable evidence

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
Thermo Fisher Scientific TMO —07May 29, 2013June 6, 2019
Healthstream Inc HSTM —06July 30, 2013May 16, 2019
Colgate-Palmolive CL —03February 4, 2022February 2, 2024

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
February 2, 2024January 31, 2024 CL Sale $233,220 +6.3%−20.6%−19.8%
February 23, 2023February 21, 2023 CL Sale $423,448 −0.1%−8.7%−10.3%
February 4, 2022February 2, 2022 CL Sale $371,675 +7.0%−0.6%+0.3%
June 6, 2019June 5, 2019 TMO Sale $74,452 +0.7%+9.9%+14.8%
May 16, 2019May 15, 2019 HSTM Sale $28,704 +10.2%−16.4%−19.0%
May 21, 2018May 18, 2018 TMO Sale $44,173 +0.8%+19.3%+16.2%
May 18, 2018May 18, 2018 HSTM Sale $14,506 +4.6%−13.9%−13.9%
May 7, 2018May 7, 2018 HSTM Sale $90,771 +1.7%−11.4%−11.8%
March 1, 2018March 1, 2018 HSTM Sale $251,475 +16.6%+10.2%+11.7%
August 31, 2017August 30, 2017 TMO Sale $65,149 −3.8%+8.2%+10.9%
August 8, 2016August 5, 2016 TMO Sale $61,359 −1.2%−4.6%−2.9%
November 4, 2015November 3, 2015 TMO Sale $71,340 +1.7%+7.7%+7.5%
June 5, 2014June 4, 2014 TMO Sale $95,799 +0.7%−1.2%−0.4%
May 12, 2014May 9, 2014 HSTM Sale $26,642 +5.2%−2.1%−0.7%
July 30, 2013July 30, 2013 HSTM Sale $10,742 +11.4%−37.5%−38.0%
May 29, 2013May 24, 2013 TMO Sale $109,885 +1.0%+14.0%+14.9%

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Harris C Martin traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.